TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells
- 12 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 213 (5) , 577-587
Abstract
TLRs are the most thoroughly studied group of pattern-recognition receptors that play a central role in innate immunity. Among them, TLR10 (CD290) remains the only TLR family member without a known ligand and clearly defined functions. One major impediment to studying TLR10 is its absence in mice. A recent study on TLR10 knock-in mice demonstrated its intrinsic inhibitory role in B cells, indicating that TLR10 is a potential drug target in autoimmune diseases. In this study, we interrogated the expression and function of TLR10 in human plasmacytoid dendritic cells (pDCs). We have seen that primary human pDCs, B cells, and monocytes constitutively express TLR10. Upon preincubation with an anti-TLR10 Ab, production of cytokines in pDCs was downregulated in response to stimulation with DNA and RNA viruses. Upon further investigation into the possible mechanism, we documented phosphorylation of STAT3 upon Ab-mediated engagement of TLR10. This leads to the induction of inhibitory molecule suppressor of cytokine signaling 3 (SOCS3) expression. We have also documented the inhibition of nuclear translocation of transcription factor IFN regulatory factor 7 (IRF7) in pDCs following TLR10 engagement. Our data provide the (to our knowledge) first evidence that TLR10 is constitutively expressed on the surface of human pDCs and works as a regulator of their innate response. Our findings indicate the potential of harnessing the function of pDCs by Ab-mediated targeting of TLR10 that may open a new therapeutic avenue for autoimmune disorders.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI026806)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI106125)
This publication has 45 references indexed in Scilit:
- Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand populationHuman Immunology, 2012
- Association between toll-like receptor 10 (TLR10) gene polymorphisms and childhood IgA nephropathyEuropean Journal of Pediatrics, 2010
- The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patientsRheumatology International, 2010
- Analyses of associations with asthma in four asthma population samples from Canada and AustraliaHuman Genetics, 2009
- Toll-like receptor heterodimer variants protect from childhood asthmaJournal of Allergy and Clinical Immunology, 2008
- Plasmacytoid dendritic cells and type I IFN: 50 years of convergent historyCytokine & Growth Factor Reviews, 2008
- Antigen Crosspresentation by Human Plasmacytoid Dendritic CellsImmunity, 2007
- Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cellsEuropean Journal of Immunology, 2004
- Of mice and men: species variations of Toll-like receptor expressionTrends in Immunology, 2002
- Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2001